Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
14
SPRC Quote, Financials, Valuation and Earnings
Last price:
$1.41
Seasonality move
:
-20.72%
Day range:
$1.38 - $1.43
52-week range:
$1.35 - $37.59
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.78x
P/B ratio:
24.89x
Volume:
54.9K
Avg. volume:
2.4M
1-year change:
-69.86%
Market cap:
$4.6M
Revenue:
$1.3M
EPS (TTM):
-$4.87
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, SciSparc Ltd. has 779901.56% upside to fair value with a price target of -- per share.
SPRC vs. S&P 500
-
Over the past 5 trading days, SciSparc Ltd. has underperformed the S&P 500 by -11.52% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SciSparc Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SciSparc Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter SciSparc Ltd. reported revenues of --.
Earnings Growth
-
SciSparc Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SciSparc Ltd. reported earnings per share of --.
Enterprise value:
4.1M
EV / Invested capital:
--
Price / LTM sales:
0.78x
EV / EBIT:
--
EV / Revenue:
4.48x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.87x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.2M
Return On Assets:
-54.04%
Net Income Margin (TTM):
-325.36%
Return On Equity:
-68.15%
Return On Invested Capital:
-68.15%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2018-06-30 | 2019-06-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -$144K | -$3K | -- | |
| Operating Income | -- | -- | -- | -$1.7M | -$197K | |
| EBITDA | -- | -- | -- | -$1.6M | $13K | |
| Diluted EPS | -- | -- | -$0.41 | -$4.74 | -$8.32 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $8.3M | $13.7M | $3.6M | $3.4M | -- | |
| Total Assets | $8.3M | $14.4M | $9.9M | $10.5M | -- | |
| Current Liabilities | $754K | $11.4M | $3.1M | $1.8M | -- | |
| Total Liabilities | $754K | $11.4M | $3.1M | $1.8M | -- | |
| Total Equity | $7.6M | $3M | $6.8M | $8.7M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2017-12-31 | 2018-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.5M | -$4.6M | -$7.1M | -$1.6M | -$2.7M | |
| Cash From Investing | -- | -- | -- | -$21K | $44K | |
| Cash From Financing | -- | -- | -- | $600.8K | $1.5M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
SPRC
Sector
Market Cap
$4.6M
$27.8M
Price % of 52-Week High
3.72%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.55%
1-Year Price Total Return
-69.86%
-17.47%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.57
200-day SMA
Sell
Level
$5.00
Bollinger Bands (100)
Sell
Level
2.05 - 4.67
Chaikin Money Flow
Sell
Level
-204.1K
20-day SMA
Sell
Level
$1.82
Relative Strength Index (RSI14)
Sell
Level
29.79
ADX Line
Sell
Level
11.68
Williams %R
Buy
Level
-94.5055
50-day SMA
Sell
Level
$2.64
MACD (12, 26)
Buy
Level
0.36
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Sell
Level
-304.8K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-9.959)
Sell
CA Score
(Annual)
Level (-2.384)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (9.579)
Sell
Piotroski F Score
(Annual)
Level (3)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments. The Drug Development segment focuses on cannabinoid molecules to be approved by an official regulatory authority. The Online Sales segment consists of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
Stock Forecast FAQ
In the current month, SPRC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SPRC average analyst price target in the past 3 months is --.
-
Where Will SciSparc Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that SciSparc Ltd. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About SciSparc Ltd.?
Analysts are divided on their view about SciSparc Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SciSparc Ltd. is a Sell and believe this share price will drop from its current level to --.
-
What Is SciSparc Ltd.'s Price Target?
The price target for SciSparc Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SPRC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SciSparc Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SPRC?
You can purchase shares of SciSparc Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SciSparc Ltd. shares.
-
What Is The SciSparc Ltd. Share Price Today?
SciSparc Ltd. was last trading at $1.41 per share. This represents the most recent stock quote for SciSparc Ltd.. Yesterday, SciSparc Ltd. closed at $1.40 per share.
-
How To Buy SciSparc Ltd. Stock Online?
In order to purchase SciSparc Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SPRC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SPRC
Sector
P/E ratio
--
23.89x
PEG ratio
--
-0.01x
P/B ratio
24.89x
1.82x
Price / LTM sales
0.78x
1.60x
Growth Metrics
SPRC
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.88%
Revenue (5-year growth)
--
6.5%
Earnings forecast
--
-$0.21
Profitability
SPRC
Sector
Profitability FY 2024
$140K
$3.5M
Return on invested capital
-68.15%
-31.77%
Return on assets
-54.04%
-27.96%
Return on equity
-68.15%
-37.63%
Earnings Date
Last Earnings Date
Dec
26
Next Earnings Date
Dec
26
Estimated Next Earnings Date
Mar
27
Balance Sheet
SPRC
Sector
Total cash
$2.6M
$26.3M
Short term investments
$517K
$25.7M
Total assets
$10.3M
$78M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 0.62% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 0.71% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 7.82% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
